Which has grown faster, ARWR or HQY?

Over the past five years, ARWR grew revenue faster — ARWR at a 44.14% CAGR versus HQY at 12.96%.

Is ARWR or HQY more profitable?

HQY runs the higher net margin — ARWR at -47.79% versus HQY at 17.36%.

How have ARWR and HQY total returns compared?

Over the past 10 years, ARWR delivered 23.56% and HQY delivered 9.16% annualized total return. Past performance doesn't predict future results.

Arrowhead Pharmaceuticals, Inc. (ARWR) vs HealthEquity, Inc. (HQY)

A side-by-side comparison of Arrowhead Pharmaceuticals, Inc. and HealthEquity, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ARWR

Arrowhead Pharmaceuticals, Inc.

$8.84B

$62.76HealthcareDelayed quote: Oct 6, 2026, 9:30 AM EDT

HQY

HealthEquity, Inc.

$7.65B

$91.52HealthcareDelayed quote: Oct 6, 2026, 9:30 AM EDT

Total return — ARWR vs HQY

growth of $100 · dividends reinvested · last 10y

ARWR +755.3% (+23.9%/yr)HQY +141.4% (+9.2%/yr)ARWR compounded faster over this window

ARWR HQY

ARWR vs HQY: by the numbers

•ARWR is the larger company ($8.84B vs $7.65B market cap).
•HQY is profitable (17.36% net margin) while ARWR runs a net loss (-47.79%).
•ARWR grew revenue faster over the past five years (44.14% vs 12.96% CAGR).

Metrics side by side

Valuation

Metric	ARWR	HQY
P/E ratio	N/A	33.04
Forward P/E	N/A	19.37
PEG ratio	N/A	0.40
P/S ratio	13.20	5.62
P/B ratio	18.99	3.84
EV / EBITDA	N/A	17.40
FCF yield	N/A	6.16%

Profitability

Metric	ARWR	HQY
Gross margin	100.00%	75.21%
Operating margin	11.86%	25.61%
Net margin	-47.79%	17.36%
ROE	-68.73%	11.88%
ROIC	-12.12%	8.55%

Growth (annualized)

Metric	ARWR	HQY
Revenue CAGR (5Y)	44.14%	12.96%
EPS CAGR (5Y)	N/A	83.56%
FCF CAGR (5Y)	N/A	36.72%
Total return CAGR (5Y)	0.75%	7.00%

Frequently asked

Which has grown faster, ARWR or HQY?: Over the past five years, ARWR grew revenue faster — ARWR at a 44.14% CAGR versus HQY at 12.96%.
Is ARWR or HQY more profitable?: HQY runs the higher net margin — ARWR at -47.79% versus HQY at 17.36%.
How have ARWR and HQY total returns compared?: Over the past 10 years, ARWR delivered 23.56% and HQY delivered 9.16% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ARWR analysis Full HQY analysis Interactive comparison tool

Dig into the metrics

HealthEquity P/E ratio Arrowhead Pharmaceuticals ROE HealthEquity ROE Arrowhead Pharmaceuticals operating margin HealthEquity operating margin Arrowhead Pharmaceuticals revenue growth HealthEquity revenue growth Arrowhead Pharmaceuticals free cash flow HealthEquity free cash flow

Arrowhead Pharmaceuticals & HealthEquity appear in these rankings

Fastest Revenue Growth Stocks Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.